Incidence and Determinants of QT Interval Prolongation in COVID-19 Patients Treated with Hydroxychloroquine and Azithromycin.
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY(2020)
Abstract
Combined use of hydroxychloroquine and azithromycin was globally adopted, in part due to paucity and high cost of alternative therapies. However the utility of these medications has been questioned; and thus safety becomes a major concern given clinical equipoise regarding efficacy. This article is protected by copyright. All rights reserved.
MoreTranslated text
Key words
azithromycin,COVID-19,hydroxychloroquine,long QT syndrome,torsades de pointes
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined